Complement activation by adaptive immune responses (mediated by IgM/IgG and the classical pathway) comes later during the course of infection, and can also (Ali et al., 2024) contribute to COVID-19 severity (Georg et al., 2022). The gene discussed is CD40LG; the disease is COVID-19.